Modular Medical (Nasdaq:MODD) announced today that it entered into definitive subscription agreements worth proceeds of approximately $12 million. The insulin patch pump maker company entered the agreements with institutional and accredited investors for a private placement. It consists of the sale of units comprised of two shares of common stock with one warrant to purchase […]
Funding Roundup
Insulet expands Omnipod 5 to more countries, prices $450M offering
Insulet (Nasdaq:PODD) announced today that it made its Omnipod 5 automated insulin delivery system available in several new geographies. The company made Omnipod 5 available in Australia and has planned launches for Belgium, Canada and Switzerland in the near term. This follows the launch of Omnipod 5 in five new European countries at the start […]
New funding supports Vitasense non-invasive glucose monitoring tech
Startup Vitasense today said it secured significant funding to advance its non-invasive wearable glucose monitoring technology. Junior high innovator Max Kopp from Germantown Academy in Pennsylvania leads the diabetes management startup. Crown Wealth, with strategic collaboration from KB Global Holding and other top universities, provided the undisclosed funding. The company said its funding marks a […]
RenovoRx prices $12.1M offering
RenovoRx (Nasdaq:RNXT) announced that it priced an underwritten public offering of common stock worth proceeds of $12.1 million. Mountain View, California-based RenovoRx priced more than 11.5 million shares of common stock at $1.05 per share. It expects the proceeds to total approximately $12.1 million before deducting underwriting discounts, commissions and offering expenses. The company plans […]
Micron Biomedical raises $33M for needle-free drug delivery tech
Micron Biomedical announced today that it added $16 million in funding to bring its Series A equity round to more than $33 million. J2 Ventures and the Global Health Investment Corporation (GHIC) led the round. Atlanta-based Micron plans to use the funds to expand commercial manufacturing for its drug delivery technology. This increases the companies […]
CeQur raises $120M to support insulin delivery tech
CeQur announced today that it closed a $120 million financing round to support its wearable insulin delivery technology. Horw, Switzerland-based CeQur plans to use the funds to drive growth and accelerate commercial expansion efforts. It aims to scale commercial teams and outreach initiatives to bring Simplicity, its four-day wearable insulin delivery device, to more healthcare […]
Beta Bionics is proposing an IPO
Beta Bionics announced today that it filed a registration statement with the SEC relating to a proposed initial public offering (IPO). The amount of shares of common stock included in the IPO and the price range remain undetermined. Irvine, California-based Beta Bionics filed to list its common stock on the Nasdaq market under the “BBNX” […]
Oura raises $200M from investors including Dexcom
Oura announced today that it completed a $200 million Series D funding round that included Dexcom (Nasdaq:DXCM). The investment comes as part of a new health monitoring partnership between the continuous glucose monitor (CGM) maker and Oura, the maker of smart ring technology. Fidelity Management & Research Co. also contributed to the financing. San Francisco–based Oura says the financing round […]
Qnovia raises $16M to support nicotine inhaler for smoking cessation therapy
Qnovia announced that it raised $16 million in Series B funding to support its inhaled smoking cessation therapy platform. Blue Ledge Capital, Evolution VC Partners, Vice Ventures and Gaingels led the financing. It brings Richmond, Virginia-based Qnovia to $50 million raised since inception. Funds raised by Qnovia support its proprietary inhaled drug delivery platform, the […]
Modular Medical brings in $8.2M
Modular Medical (Nasdaq:MODD) announced recently that it priced an underwritten public offering worth proceeds of around $8.2 million. The San Diego-based insulin pump maker intends to offer more than 5.45 million shares of its common stock at $1.50 per share. It expects proceeds to total $8.2 million before deducting discounts, commissions and estimated offering expenses. The […]
